Irving Wiesen

Irving L. Wiesen has had over twenty-five years experience in the food & drug and device industry, representing a broad spectrum of brand name and generic pharmaceutical and medical device clients, both domestic and international. He engages in all major aspects of law particular to the pharmaceutical industry, including regulatory counseling on FDA applications, general compliance, product development and approval strategies, advertising and marketing compliance, cGMP compliance, negotiating and drafting commercial, marketing, development and technology licensing agreements, FTC and DEA practice, import and export regulations, antitrust, and personnel and employment issues.

Previously, Mr. Wiesen was a partner at Bass & Ullman, a well-known pioneering food and drug law firm as well as Division Counsel at Boehringer Ingelheim Pharmaceuticals Inc., a large, multi-national research-based pharmaceutical company. Mr. Wiesen has appeared in court and in many other federal and state administrative and international forums on behalf of his clients and has scored many notable successes on their behalf. Mr. Wiesen has extensive contacts throughout the industry, including at the FDA.

Mr. Wiesen has lectured and published extensively on matters related to food and drug law and the pharmaceutical industry.